TrialThe European respiratory journal2023

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).

Jatin Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.